Global Intermittently Scanned Continuous Glucose Monitor Market Strategic Research Report

Scope of the Report

The global Intermittently Scanned Continuous Glucose Monitor market size is predicted to grow from US$ 9,685 million in 2025 to US$ 14,165 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

In 2025, global Intermittently Scanned Continuous Glucose Monitor production reached approximately 180 million units, and the average price was US$55 per unit.The Intermittently Scanned Continuous Glucose Monitor (isCGM) is a wearable medical device designed for the dynamic management of blood glucose in patients with diabetes. It utilizes a subcutaneous sensor to continuously monitor glucose concentrations in interstitial fluid and stores glucose data over a specific period within the sensor itself; users obtain real-time glucose readings, trend arrows, and historical trend curves by scanning the sensor. The system typically comprises a disposable glucose sensor, a scanning reader or smartphone app, a data management platform, and supporting software. Unlike real-time continuous glucose monitoring (rtCGM) systems, isCGM generally does not actively and continuously transmit alerts; instead, data is retrieved when the user actively scans the device. Consequently, it offers advantages such as a longer wear duration, ease of use, and relatively lower costs. These products are widely used for patients with Type 1 diabetes, patients with Type 2 diabetes undergoing insulin therapy, and in scenarios requiring precise blood glucose management, serving as a crucial component of digital diabetes care.

The industry is currently driven by the rising number of diabetes patients, the digitalization of blood glucose management, the widespread adoption of home health monitoring, and the gradual improvement of medical payment systems; it is evolving from a sector focused solely on glucose monitoring devices into one providing intelligent chronic disease management solutions. Key opportunities lie in the mass adoption of low-cost CGM, direct smartphone connectivity, out-of-hospital diabetes management, blood glucose management in primary care settings, applications for pediatric and elderly patients, and data interoperability with insulin pumps and health management platforms. Core industry competitiveness is defined by sensor accuracy, wear comfort, sensor lifespan, data stability, algorithmic analysis capabilities, smartphone ecosystem compatibility, and medical data management proficiency. Current industry challenges include high sensor costs, the financial burden of long-term use for some patients, the impact of scanning reliance on data continuity, skin allergy issues, insufficient data interoperability between devices, and limited efficiency in data interpretation by clinicians. Solutions involve improving sensor manufacturing processes, extending sensor longevity, optimizing non-invasive or minimally invasive detection technologies, enhancing AI-driven glucose trend analysis, promoting data integration across medical platforms, and improving patient adherence through telemedicine services. Overall, the industry is transitioning from simple glucose monitoring toward comprehensive diabetes management characterized by personalization, intelligence, and connectivity.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intermittently Scanned Continuous Glucose Monitor market?

What factors are driving Intermittently Scanned Continuous Glucose Monitor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intermittently Scanned Continuous Glucose Monitor market opportunities vary by end market size?

How does Intermittently Scanned Continuous Glucose Monitor break out by Type, by Application?

This report presents a comprehensive overview of the global Intermittently Scanned Continuous Glucose Monitor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Electrochemical Enzyme Sensor Type
• Microneedle Sensor Type
• Flexible Electronic Sensor Type

Segment by Cycle

• Short Cycle (≤7 Days)
• Standard Cycle (8–14 Days)
• Long Cycle (15–30 Days)

Segment by Application

• Hospital
• Home-Based Management
• Exercise and Health
• Insulin Therapy Support and Management
• Telemedicine

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Intermittently Scanned Continuous Glucose Monitor market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Home-Based Management, Exercise and Health evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact